Niklas Boknäs




Kjersti Tunströmer, Lars Faxälv, Pia Larsson, Tomas Lindahl, Niklas Boknäs (2023) Thrombus remodelling by reversible and irreversible P2Y(12) inhibitors Platelets, Vol. 34, Artikel 2157805 Vidare till DOI


P. Larsson, V Tarlac, T-Y Wang, T. Bonnard, C. E. Hagemeyer, J. R. Hamilton, R. L. Medcalf, S. H. Cody, Niklas Boknäs (2022) Scanning laser-induced endothelial injury: a standardized and reproducible thrombosis model for intravital microscopy Scientific Reports, Vol. 12, Artikel 3955 Vidare till DOI
Niklas Boknäs, Cia Laine, Andreas Hillarp, Ankit Macwan, Kerstin Gustafsson, Tomas Lindahl, Margareta Holmström (2022) Associations between hemostatic markers and mortality in COVID-19-Compounding effects of D-dimer, antithrombin and PAP complex Thrombosis Research, Vol. 213, s. 97-104 Vidare till DOI


Mikael Lund, Ankit Macwan, Kjersti Tunströmer, Tomas Lindahl, Niklas Boknäs (2021) Effects of Heparin and Bivalirudin on Thrombin-Induced Platelet Activation: Differential Modulation of PAR Signaling Drives Divergent Prothrombotic Responses Frontiers in Cardiovascular Medicine, Vol. 8, Artikel 717835 Vidare till DOI


Suryyani Deb, Niklas Boknäs, Clara Sjöström, Anjana Tharmakulanathan, Kourosh Lotfi, Sofia Ramström (2020) Varying effects of tyrosine kinase inhibitors on platelet function-A need for individualized CML treatment to minimize the risk for hemostatic and thrombotic complications? Cancer Medicine, Vol. 9, s. 313-323 Vidare till DOI